Chronic Kidney Disease
3 min read
SGLT2 Inhibitors and Skeletal Safety in Patients with Chronic Kidney Disease: Key Points from a Systematic Review
A systematic review found limited and inconsistent evidence on the effects of SGLT2 inhibitors on bone health in CKD patients, with particularly scarce data in advanced CKD populations [1].
